"Cancer Specialists of Tidewater and Infusion Center, a division of Riverside Regional Medical Center, is a full-service cancer treatment network dedicated to healing and specializing in compassionate state-of-the-art cancer treatment. With three locations on the Southside, our team of experts is composed of physicians who are board-certified in hematology, medical oncology, and palliative medicine, oncology certified registered nurses, a certified family nurse practitioner, a clinical research team, ASCP laboratory technicians, knowledgeable financial counselors, certified medical assistants, and friendly, professional front desk staff who all work together to provide patients and their families the best care possible. Cancer Specialists of"

During the past decade, Peninsula Cancer Institute-Cancer Specialists of Tidewater conducted 13 clinical trials. In the 10-year time frame, 13 clinical trials started and 2 clinical trials were completed, i.e. on average, 15.4% percent of trials that started reached the finish line to date. In the past 5 years, 10 clinical trials started and 1 clinical trials were completed. i.e. 10% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Peninsula Cancer Institute-Cancer Specialists of Tidewater" #1 sponsor was "Accelerated Community Oncology Research Network" with 6 trials, followed by "National Cancer Institute (NCI)" with 6 trials sponsored, "Alliance for Clinical Trials in Oncology" with 4 trials sponsored, "NRG Oncology" with 2 trials sponsored and "SWOG Cancer Research Network" with 2 trials sponsored. Other sponsors include 1 different institutions and companies that sponsored additional 11 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Peninsula Cancer Institute-Cancer Specialists of Tidewater" #1 collaborator was "National Cancer Institute (NCI)" with 11 trials as a collaborator, "Genentech, Inc." with 2 trials as a collaborator, "AstraZeneca" with 1 trials as a collaborator, "Bayer" with 1 trials as a collaborator and "Celgene Corporation" with 1 trials as a collaborator. Other collaborators include 2 different institutions and companies that were collaborators in the rest 12 trials.

According to Clinical.Site data, the most researched conditions in "Peninsula Cancer Institute-Cancer Specialists of Tidewater" are "Invasive Breast Carcinoma" (5 trials), "Anatomic Stage II Breast Cancer AJCC v8" (3 trials), "Prognostic Stage II Breast Cancer AJCC v8" (3 trials), "Anatomic Stage IIA Breast Cancer AJCC v8" (2 trials) and "Anatomic Stage IIB Breast Cancer AJCC v8" (2 trials). Many other conditions were trialed in "Peninsula Cancer Institute-Cancer Specialists of Tidewater" in a lesser frequency.

Most popular intervention types in "Peninsula Cancer Institute-Cancer Specialists of Tidewater" are "Drug" (22 trials), "Other" (12 trials), "Biological" (6 trials), "Procedure" (4 trials) and "Behavioral" (2 trials). Other intervention types were less common.

The name of intervention was led by "Quality-of-Life Assessment" (8 trials), "Paclitaxel" (5 trials), "Questionnaire Administration" (5 trials), "Cyclophosphamide" (4 trials) and "Laboratory Biomarker Analysis" (4 trials). Other intervention names were less common.

The vast majority of trials in "Peninsula Cancer Institute-Cancer Specialists of Tidewater" are 18 trials for "All" genders, 7 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Peninsula Cancer Institute-Cancer Specialists of Tidewater". undefined are not yet recruiting, 9 are recruiting, 6 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Peninsula Cancer Institute-Cancer Specialists of Tidewater, 2 suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Peninsula Cancer Institute-Cancer Specialists of Tidewater, 0 "Phase 1" clinical trials were conducted, 11 "Phase 2" clinical trials and 14 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 1 trials that are defined as “Not Applicable".